Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 2 | History Defined

Walgreens Announces $683M Opioid Settlement With Florida

Walgreens Boots Alliance Inc (NASDAQ:WBA) has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state. The settlement includes $620 million to be paid to Florida over 18 years, plus $63 million for legal fees. The settlement ends a trial that began…

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

Reliance studying possible bid for Walgreens’s boots chain

Reliance studying possible bid for Walgreens’s boots chain

NEW DELHI: Billionaire Mukesh Ambani’s Reliance Industries is weighing a possible bid for Walgreens Boots Alliance Inc’s international drugstore unit, according to people familiar with the matter.

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Analyzing Walgreens Boots Alliance Inc's Short Interest

Walgreens Boots Alliance Inc's (NASDAQ:WBA) short percent of float has fallen 14.69% since its last report. The company recently reported that it has 17.45 million shares sold short, which is 2.44% of all regular shares that are available for trading.

CNBC's Final Trades: CVS Health, AbbVie, iShares US Aerospace & Defense ETF And This 'All-Weather' Stock

On CNBC’s “Halftime Report Final Trades,” Stephanie Link of Hightower said Walgreens Boots Alliance Inc’s (NASDAQ: WBA) stock is “down 11% year to date, 8.5 times ear

Walgreens Stock Fell 8% This Week: What Happened?

Walgreens Boots Alliance Inc (NASDAQ: WBA) shares continue to trade lower Friday after the company on Thursday reported financial results and reaffirmed soft guidance for low-single digit earnings growth.

Why Walgreens Boots Alliance Shares Are Plunging Today

Walgreens Boots Alliance Inc's (NASDAQ:WBA) Q2 FY22 sales increased 3% Y/Y to $33.8 billion, up 3.8% on a constant currency basis, beating the consensus of $33.36 billion. Omicron variant of COVID-19 intensified demand for booster shots and tests and drove foot traffic during the winter months. Adjusted EPS reached $1.59, beating the…

inkl

Read news from The Economist, FT, and more,
with one subscription

5 Value Stocks to Reinforce Your Portfolio in Q2 2022

5 Value Stocks to Reinforce Your Portfolio in Q2 2022

Due to concerns over the possibility of aggressive interest rate increases and the consequences of a prolonged Ukraine-Russia war, current market volatility has caused many quality stocks to trade at attractive valuations. For example, fundamentally sound stocks Lockheed Martin (LMT), HCA Healthcare (HCA), FedEx (FDX), Enterprise Products (EPD), and Walgreens…

How Is The Market Feeling About Walgreens Boots Alliance Inc?

How Is The Market Feeling About Walgreens Boots Alliance Inc?

Walgreens Boots Alliance Inc's (NASDAQ:WBA) short percent of float has risen 10.0% since its last report. The company recently reported that it has 20.39 million shares sold short, which is 2.86% of all regular shares that are available for trading.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Reliance Industries

Walgreens Boots Alliance

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

389,341 stories

142,311 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play